Fredun Pharmaceuticals share news, announcements and annual reports
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,367.00.
2 Nov: open ₹1,360.00, high ₹1,420.00, low ₹1,350.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,380 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,78644.2% delivered
Fredun Pharmaceuticals share news and announcements
665 announcements, routine notices left out, newest first. Page 9 of 14.
Apr 2021
16 Apr · Half Yearly Certificate Under Regulation 40 (9) & 40 (10) Of SEBI Listing Regulations, 2015
9 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....2 Apr · Compliance Certificate For The Half Year Ended 31St March, 2021
2 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0 <t
Feb 2021
23 Feb · Announcement Under Regulation 30 (LODR)- Company's Way Forward
Jan 2021
28 Jan · Board meeting
Meeting on 12 Feb 2021: quarterly results11 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....4 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2020
30 Dec · Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations
Nov 2020
Oct 2020
26 Oct · Board meeting
Meeting on 9 Nov 2020: quarterly results24 Oct · Half Yearly Certificate Under Regulations 40(9) & 40(10) Of SEBI Listing Regulations, 2015
14 Oct · Disclosure Under Regulation 30 Of SEBI (LODR) Regulations
12 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....12 Oct · Compliance Certificate For The Period Ended September 2020
5 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
29 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....28 Sep · Meeting
5 Sep · Reg. 34 (1) Annual Report
4 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results
Aug 2020
Jul 2020
30 Jul · Disclosure Of Material Impact Of COVID-19 Pandemic On Listed Entities Under LODR (Listing Obligations And Disclosure Requirements) Regulations,2015
27 Jul · Board meeting
Meeting on 29 Jul 2020: audited results24 Jul · Legal
Exchange has sought clarification from Fredun Pharmaceuticals Ltd on July 24, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....10 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....7 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
May 2020
21 May · Certificate Under Regulation 40(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015 For The Half Year Ended 31St March, 2020.
18 May · Compliance Certificate For The Period Ended 31St March, 2020.
11 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
16 Apr · Legal
Exchange has sought clarification from Fredun Pharmaceuticals Ltd on April 16th , 2020 with reference to significant movement in price, in order to ensure that investors have latest ....7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2020
Jan 2020
31 Jan · Management